Hemoglobin affects lipid peroxidation and prostaglandin E2 formation in rat corticocerebral tissues in vitro

Variations of lipid peroxidation and arachidonic acid (AA) metabolism products were found when experimental subarachnoid hemorrhage or ischemia and reperfusion were performed in an animal brain model. In a previous study, we showed that hemoglobin (Hb) produces prostaglandins when incubated in AA. T...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical pharmacology 1996-07, Vol.52 (1), p.97-104
Hauptverfasser: CIUFFI, M, TARLINI, L, MUGNAI, S, FRANCHI-MICHELI, S, ZILLETTI, L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 104
container_issue 1
container_start_page 97
container_title Biochemical pharmacology
container_volume 52
creator CIUFFI, M
TARLINI, L
MUGNAI, S
FRANCHI-MICHELI, S
ZILLETTI, L
description Variations of lipid peroxidation and arachidonic acid (AA) metabolism products were found when experimental subarachnoid hemorrhage or ischemia and reperfusion were performed in an animal brain model. In a previous study, we showed that hemoglobin (Hb) produces prostaglandins when incubated in AA. To elucidate how Hb affects lipid peroxidation and AA metabolism in the CNS, we measured lipid hydroperoxides (LOOH), PGE2 and thiobarbituric acid reactant substances (TBARS) in corticocerebral homogenates and slices of rats (normal rats) after incubation with different concentrations (10(-9) to 10(-5) M) of Hb. In addition, brain cortices of indomethacin-treated (40 mg/Kg) rats (IN-treated rat) were incubated in the presence of 10(-5) M indomethacin (IN) to exclude the interference of prostaglandin enzyme synthetase. Hb was able to affect LOOH, PGE2, and TBARS production in both normal and IN-treated rat brain cortex homogenates and slices. In all cases, we found an increase in prostaglandin when 10(-8) M Hb was used, whereas no effect was noticed with 10(-9) M. On the other hand, with higher Hb concentrations (10(-6)-10(-5) M), the LOOH and PGE2 values did not reach statistical significance, and TBARS significantly increased. In all cases, when 10(-4) M scavenger or metal-chelating compounds were added to an incubation mixture with 10(-8) M Hb, PGE2 formation was inhibited, whereas no variation occurred when 10(-4) M IN was further added to IN-treated rat corticocerebral homogenate or slices. We hypothesize that in in vivo experimental neuropathologies, Hb must attain the 10(-8) M concentration in the reaction cellular microenvironment to stimulate PGE2 production, and that an evaluable part of this PGE2 production may be directly ascribable to the iron-heme oxy-redoxy activity of Hb.
doi_str_mv 10.1016/0006-2952(96)00169-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78145039</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78145039</sourcerecordid><originalsourceid>FETCH-LOGICAL-c312t-e918f5d88a4ff7699f12b0bf475e6a3896638626fb4cd924809e31b6e217e7e53</originalsourceid><addsrcrecordid>eNo9UMtKAzEUDaJorf6BwixEdDGa12SSpZT6AMGNrkMmcyORmaYmqejfm6Glq-Q87uXcg9AFwXcEE3GPMRY1VQ29UeIWF0bV_ADNiGxZoYU8RLO95QSdpvQ1QSnIMTqWopWKsBkanmEMn0Po_KoyzoHNqRr82vfVGmL49b3JPhRpVYgYUjafQ_kX85JWLsRxKxccTa5siNnbYCFCF81QZZ_SBtIk__gcwxk6cmZIcL575-jjcfm-eK5f355eFg-vtWWE5hoUka7ppTTcuVYo5QjtcOd424AwTCohmBRUuI7bXlEusQJGOgGUtNBCw-boeru3RP4uAbIefbIwlOgQNkm3kvAGM1WMfGu05bYUwel19KOJf5pgPZWsp8r01KBWEygla17GLnf7N90I_X5o12rRr3a6SdYMLpqV9WlvY4Rj2rTsH1cIhZ0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78145039</pqid></control><display><type>article</type><title>Hemoglobin affects lipid peroxidation and prostaglandin E2 formation in rat corticocerebral tissues in vitro</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>CIUFFI, M ; TARLINI, L ; MUGNAI, S ; FRANCHI-MICHELI, S ; ZILLETTI, L</creator><creatorcontrib>CIUFFI, M ; TARLINI, L ; MUGNAI, S ; FRANCHI-MICHELI, S ; ZILLETTI, L</creatorcontrib><description>Variations of lipid peroxidation and arachidonic acid (AA) metabolism products were found when experimental subarachnoid hemorrhage or ischemia and reperfusion were performed in an animal brain model. In a previous study, we showed that hemoglobin (Hb) produces prostaglandins when incubated in AA. To elucidate how Hb affects lipid peroxidation and AA metabolism in the CNS, we measured lipid hydroperoxides (LOOH), PGE2 and thiobarbituric acid reactant substances (TBARS) in corticocerebral homogenates and slices of rats (normal rats) after incubation with different concentrations (10(-9) to 10(-5) M) of Hb. In addition, brain cortices of indomethacin-treated (40 mg/Kg) rats (IN-treated rat) were incubated in the presence of 10(-5) M indomethacin (IN) to exclude the interference of prostaglandin enzyme synthetase. Hb was able to affect LOOH, PGE2, and TBARS production in both normal and IN-treated rat brain cortex homogenates and slices. In all cases, we found an increase in prostaglandin when 10(-8) M Hb was used, whereas no effect was noticed with 10(-9) M. On the other hand, with higher Hb concentrations (10(-6)-10(-5) M), the LOOH and PGE2 values did not reach statistical significance, and TBARS significantly increased. In all cases, when 10(-4) M scavenger or metal-chelating compounds were added to an incubation mixture with 10(-8) M Hb, PGE2 formation was inhibited, whereas no variation occurred when 10(-4) M IN was further added to IN-treated rat corticocerebral homogenate or slices. We hypothesize that in in vivo experimental neuropathologies, Hb must attain the 10(-8) M concentration in the reaction cellular microenvironment to stimulate PGE2 production, and that an evaluable part of this PGE2 production may be directly ascribable to the iron-heme oxy-redoxy activity of Hb.</description><identifier>ISSN: 0006-2952</identifier><identifier>EISSN: 1873-2968</identifier><identifier>DOI: 10.1016/0006-2952(96)00169-4</identifier><identifier>PMID: 8678913</identifier><identifier>CODEN: BCPCA6</identifier><language>eng</language><publisher>New York, NY: Elsevier Science</publisher><subject>Animals ; Biological and medical sciences ; Cerebral Cortex - drug effects ; Cerebral Cortex - enzymology ; Cerebral Cortex - metabolism ; Cyclooxygenase Inhibitors - pharmacology ; Deferoxamine - pharmacology ; Dinoprostone - biosynthesis ; Free Radical Scavengers - pharmacology ; Hemoglobins - pharmacology ; In Vitro Techniques ; Indomethacin - pharmacology ; Iron Chelating Agents - pharmacology ; Lipid Peroxidation - drug effects ; Male ; Medical sciences ; Neurology ; Penicillamine - pharmacology ; Rats ; Rats, Wistar ; Vascular diseases and vascular malformations of the nervous system ; Vitamin E - pharmacology</subject><ispartof>Biochemical pharmacology, 1996-07, Vol.52 (1), p.97-104</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c312t-e918f5d88a4ff7699f12b0bf475e6a3896638626fb4cd924809e31b6e217e7e53</citedby><cites>FETCH-LOGICAL-c312t-e918f5d88a4ff7699f12b0bf475e6a3896638626fb4cd924809e31b6e217e7e53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3140257$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8678913$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CIUFFI, M</creatorcontrib><creatorcontrib>TARLINI, L</creatorcontrib><creatorcontrib>MUGNAI, S</creatorcontrib><creatorcontrib>FRANCHI-MICHELI, S</creatorcontrib><creatorcontrib>ZILLETTI, L</creatorcontrib><title>Hemoglobin affects lipid peroxidation and prostaglandin E2 formation in rat corticocerebral tissues in vitro</title><title>Biochemical pharmacology</title><addtitle>Biochem Pharmacol</addtitle><description>Variations of lipid peroxidation and arachidonic acid (AA) metabolism products were found when experimental subarachnoid hemorrhage or ischemia and reperfusion were performed in an animal brain model. In a previous study, we showed that hemoglobin (Hb) produces prostaglandins when incubated in AA. To elucidate how Hb affects lipid peroxidation and AA metabolism in the CNS, we measured lipid hydroperoxides (LOOH), PGE2 and thiobarbituric acid reactant substances (TBARS) in corticocerebral homogenates and slices of rats (normal rats) after incubation with different concentrations (10(-9) to 10(-5) M) of Hb. In addition, brain cortices of indomethacin-treated (40 mg/Kg) rats (IN-treated rat) were incubated in the presence of 10(-5) M indomethacin (IN) to exclude the interference of prostaglandin enzyme synthetase. Hb was able to affect LOOH, PGE2, and TBARS production in both normal and IN-treated rat brain cortex homogenates and slices. In all cases, we found an increase in prostaglandin when 10(-8) M Hb was used, whereas no effect was noticed with 10(-9) M. On the other hand, with higher Hb concentrations (10(-6)-10(-5) M), the LOOH and PGE2 values did not reach statistical significance, and TBARS significantly increased. In all cases, when 10(-4) M scavenger or metal-chelating compounds were added to an incubation mixture with 10(-8) M Hb, PGE2 formation was inhibited, whereas no variation occurred when 10(-4) M IN was further added to IN-treated rat corticocerebral homogenate or slices. We hypothesize that in in vivo experimental neuropathologies, Hb must attain the 10(-8) M concentration in the reaction cellular microenvironment to stimulate PGE2 production, and that an evaluable part of this PGE2 production may be directly ascribable to the iron-heme oxy-redoxy activity of Hb.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cerebral Cortex - drug effects</subject><subject>Cerebral Cortex - enzymology</subject><subject>Cerebral Cortex - metabolism</subject><subject>Cyclooxygenase Inhibitors - pharmacology</subject><subject>Deferoxamine - pharmacology</subject><subject>Dinoprostone - biosynthesis</subject><subject>Free Radical Scavengers - pharmacology</subject><subject>Hemoglobins - pharmacology</subject><subject>In Vitro Techniques</subject><subject>Indomethacin - pharmacology</subject><subject>Iron Chelating Agents - pharmacology</subject><subject>Lipid Peroxidation - drug effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neurology</subject><subject>Penicillamine - pharmacology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Vascular diseases and vascular malformations of the nervous system</subject><subject>Vitamin E - pharmacology</subject><issn>0006-2952</issn><issn>1873-2968</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9UMtKAzEUDaJorf6BwixEdDGa12SSpZT6AMGNrkMmcyORmaYmqejfm6Glq-Q87uXcg9AFwXcEE3GPMRY1VQ29UeIWF0bV_ADNiGxZoYU8RLO95QSdpvQ1QSnIMTqWopWKsBkanmEMn0Po_KoyzoHNqRr82vfVGmL49b3JPhRpVYgYUjafQ_kX85JWLsRxKxccTa5siNnbYCFCF81QZZ_SBtIk__gcwxk6cmZIcL575-jjcfm-eK5f355eFg-vtWWE5hoUka7ppTTcuVYo5QjtcOd424AwTCohmBRUuI7bXlEusQJGOgGUtNBCw-boeru3RP4uAbIefbIwlOgQNkm3kvAGM1WMfGu05bYUwel19KOJf5pgPZWsp8r01KBWEygla17GLnf7N90I_X5o12rRr3a6SdYMLpqV9WlvY4Rj2rTsH1cIhZ0</recordid><startdate>19960712</startdate><enddate>19960712</enddate><creator>CIUFFI, M</creator><creator>TARLINI, L</creator><creator>MUGNAI, S</creator><creator>FRANCHI-MICHELI, S</creator><creator>ZILLETTI, L</creator><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960712</creationdate><title>Hemoglobin affects lipid peroxidation and prostaglandin E2 formation in rat corticocerebral tissues in vitro</title><author>CIUFFI, M ; TARLINI, L ; MUGNAI, S ; FRANCHI-MICHELI, S ; ZILLETTI, L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c312t-e918f5d88a4ff7699f12b0bf475e6a3896638626fb4cd924809e31b6e217e7e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cerebral Cortex - drug effects</topic><topic>Cerebral Cortex - enzymology</topic><topic>Cerebral Cortex - metabolism</topic><topic>Cyclooxygenase Inhibitors - pharmacology</topic><topic>Deferoxamine - pharmacology</topic><topic>Dinoprostone - biosynthesis</topic><topic>Free Radical Scavengers - pharmacology</topic><topic>Hemoglobins - pharmacology</topic><topic>In Vitro Techniques</topic><topic>Indomethacin - pharmacology</topic><topic>Iron Chelating Agents - pharmacology</topic><topic>Lipid Peroxidation - drug effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neurology</topic><topic>Penicillamine - pharmacology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Vascular diseases and vascular malformations of the nervous system</topic><topic>Vitamin E - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CIUFFI, M</creatorcontrib><creatorcontrib>TARLINI, L</creatorcontrib><creatorcontrib>MUGNAI, S</creatorcontrib><creatorcontrib>FRANCHI-MICHELI, S</creatorcontrib><creatorcontrib>ZILLETTI, L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CIUFFI, M</au><au>TARLINI, L</au><au>MUGNAI, S</au><au>FRANCHI-MICHELI, S</au><au>ZILLETTI, L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hemoglobin affects lipid peroxidation and prostaglandin E2 formation in rat corticocerebral tissues in vitro</atitle><jtitle>Biochemical pharmacology</jtitle><addtitle>Biochem Pharmacol</addtitle><date>1996-07-12</date><risdate>1996</risdate><volume>52</volume><issue>1</issue><spage>97</spage><epage>104</epage><pages>97-104</pages><issn>0006-2952</issn><eissn>1873-2968</eissn><coden>BCPCA6</coden><abstract>Variations of lipid peroxidation and arachidonic acid (AA) metabolism products were found when experimental subarachnoid hemorrhage or ischemia and reperfusion were performed in an animal brain model. In a previous study, we showed that hemoglobin (Hb) produces prostaglandins when incubated in AA. To elucidate how Hb affects lipid peroxidation and AA metabolism in the CNS, we measured lipid hydroperoxides (LOOH), PGE2 and thiobarbituric acid reactant substances (TBARS) in corticocerebral homogenates and slices of rats (normal rats) after incubation with different concentrations (10(-9) to 10(-5) M) of Hb. In addition, brain cortices of indomethacin-treated (40 mg/Kg) rats (IN-treated rat) were incubated in the presence of 10(-5) M indomethacin (IN) to exclude the interference of prostaglandin enzyme synthetase. Hb was able to affect LOOH, PGE2, and TBARS production in both normal and IN-treated rat brain cortex homogenates and slices. In all cases, we found an increase in prostaglandin when 10(-8) M Hb was used, whereas no effect was noticed with 10(-9) M. On the other hand, with higher Hb concentrations (10(-6)-10(-5) M), the LOOH and PGE2 values did not reach statistical significance, and TBARS significantly increased. In all cases, when 10(-4) M scavenger or metal-chelating compounds were added to an incubation mixture with 10(-8) M Hb, PGE2 formation was inhibited, whereas no variation occurred when 10(-4) M IN was further added to IN-treated rat corticocerebral homogenate or slices. We hypothesize that in in vivo experimental neuropathologies, Hb must attain the 10(-8) M concentration in the reaction cellular microenvironment to stimulate PGE2 production, and that an evaluable part of this PGE2 production may be directly ascribable to the iron-heme oxy-redoxy activity of Hb.</abstract><cop>New York, NY</cop><pub>Elsevier Science</pub><pmid>8678913</pmid><doi>10.1016/0006-2952(96)00169-4</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-2952
ispartof Biochemical pharmacology, 1996-07, Vol.52 (1), p.97-104
issn 0006-2952
1873-2968
language eng
recordid cdi_proquest_miscellaneous_78145039
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Animals
Biological and medical sciences
Cerebral Cortex - drug effects
Cerebral Cortex - enzymology
Cerebral Cortex - metabolism
Cyclooxygenase Inhibitors - pharmacology
Deferoxamine - pharmacology
Dinoprostone - biosynthesis
Free Radical Scavengers - pharmacology
Hemoglobins - pharmacology
In Vitro Techniques
Indomethacin - pharmacology
Iron Chelating Agents - pharmacology
Lipid Peroxidation - drug effects
Male
Medical sciences
Neurology
Penicillamine - pharmacology
Rats
Rats, Wistar
Vascular diseases and vascular malformations of the nervous system
Vitamin E - pharmacology
title Hemoglobin affects lipid peroxidation and prostaglandin E2 formation in rat corticocerebral tissues in vitro
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T21%3A56%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hemoglobin%20affects%20lipid%20peroxidation%20and%20prostaglandin%20E2%20formation%20in%20rat%20corticocerebral%20tissues%20in%20vitro&rft.jtitle=Biochemical%20pharmacology&rft.au=CIUFFI,%20M&rft.date=1996-07-12&rft.volume=52&rft.issue=1&rft.spage=97&rft.epage=104&rft.pages=97-104&rft.issn=0006-2952&rft.eissn=1873-2968&rft.coden=BCPCA6&rft_id=info:doi/10.1016/0006-2952(96)00169-4&rft_dat=%3Cproquest_cross%3E78145039%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78145039&rft_id=info:pmid/8678913&rfr_iscdi=true